Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept Study

NCT02271165 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT02271165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02271165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept Study
Lead sponsor
Thomas Jefferson University
Phase
Phase 1
Overall status
Terminated
Start date
November 30, 2014
Completion date
March 2, 2017
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dermatomyositis